We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.54B
AUM Growth
+$215M
Cap. Flow
-$203M
Cap. Flow %
-2.69%
Top 10 Hldgs %
62.44%
Holding
434
New
139
Increased
87
Reduced
85
Closed
95

Top Buys

Rank Stock Value
1
CYTK icon
Cytokinetics
CYTK
+$118M
2
INCY icon
Incyte
INCY
+$117M
3
GRFS
Grifois
GRFS
+$51.9M
4
HUM icon
Humana
HUM
+$47.4M
5
KO icon
Coca-Cola
KO
+$45.2M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$88.4M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$80.1M
3
FRPT icon
Freshpet
FRPT
+$60.8M
4
AMZN icon
Amazon
AMZN
+$55.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$50.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Staples 5.54%
3 Consumer Discretionary 5.08%
4 Technology 3.55%
5 Communication Services 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRFS
26
Grifois
GRFS
$5.49B
$44.4M 0.59%
+6,648,000
New +$51.9M
BHVN icon
27
Biohaven
BHVN
$2.07B
$43.7M 0.58%
799,263
-700,737
-47% -$34.7M
KURA icon
28
Kura Oncology
KURA
$841M
$43.7M 0.58%
2,048,000
-176,000
-8% -$3.42M
VYGR icon
29
Voyager Therapeutics
VYGR
$189M
$43.5M 0.58%
4,672,000
+436,000
+10% +$3.68M
HUM icon
30
Humana
HUM
$43.5B
$43.4M 0.58%
+125,184
New +$47.4M
SBUX icon
31
Starbucks
SBUX
$120B
$43M 0.57%
470,070
+191,603
+69% +$17.8M
BUD icon
32
AB InBev
BUD
$167B
$42.7M 0.57%
702,000
+295,000
+72% +$18.5M
BCYC
33
Bicycle Therapeutics
BCYC
$275M
$41.6M 0.55%
1,672,000
+136,000
+9% +$2.89M
GSK icon
34
GSK
GSK
$103B
$41.3M 0.55%
964,000
-1,232,000
-56% -$50.8M
SHAK icon
35
Shake Shack
SHAK
$2.67B
$35.7M 0.47%
342,954
+191,670
+127% +$16.8M
MGNX icon
36
MacroGenics
MGNX
$248M
$35.3M 0.47%
2,400,000
-2,172,000
-48% -$32.8M
K
37
DELISTED
Kellanova
K
$33.1M 0.44%
577,920
-7,080
-1% -$390K
TMCI icon
38
Treace Medical Concepts
TMCI
$307M
$31.3M 0.42%
2,400,000
-456,000
-16% -$6.08M
KVUE icon
39
Kenvue
KVUE
$37.5B
$31M 0.41%
1,443,029
+973,029
+207% +$19.8M
AUTL
40
Autolus Therapeutics
AUTL
$519M
$29.8M 0.4%
4,672,000
+822,000
+21% +$5.13M
SAM icon
41
Boston Beer
SAM
$1.92B
$29.3M 0.39%
96,199
+33,988
+55% +$11.3M
FIVN icon
42
FIVE9
FIVN
$2.28B
$28.6M 0.38%
461,106
+273,106
+145% +$19M
DYN icon
43
Dyne Therapeutics
DYN
$4.85B
$28.4M 0.38%
1,000,000
+176,000
+21% +$3.98M
THS
44
DELISTED
Treehouse Foods
THS
$27.2M 0.36%
698,000
+191,000
+38% +$7.56M
PRTA icon
45
Prothena Corp
PRTA
$444M
$27.1M 0.36%
1,096,000
+818,000
+294% +$24.3M
POST icon
46
Post Holdings
POST
$4.11B
$26.8M 0.36%
252,127
-209,250
-45% -$21M
NOMD icon
47
Nomad Foods
NOMD
$1.66B
$26.4M 0.35%
1,351,510
-52,123
-4% -$960K
SXT icon
48
Sensient Technologies
SXT
$5.41B
$26.2M 0.35%
+379,000
New +$24.6M
TXRH icon
49
Texas Roadhouse
TXRH
$13.7B
$26.1M 0.35%
168,780
-66,220
-28% -$9.08M
SYY icon
50
Sysco
SYY
$39.6B
$25.5M 0.34%
314,625
+147,583
+88% +$11.6M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Armistice Capital held 434 positions worth $7.54B, up 2.9% from $7.33B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q1 2024 filing shows 139 new, 87 increased, 85 reduced and 95 closed positions. Its largest new stake was Cytokinetics: 1,525,688 shares worth $107M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $88.4M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

  • Armistice Capital's largest Q1 2024 buy was Cytokinetics: 1,525,688 shares worth $107M.
  • Armistice Capital added most to Incyte in Q1 2024, an estimated $117M increase.
  • Armistice Capital's biggest Q1 2024 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $88.4M.
  • Armistice Capital fully exited Jazz Pharmaceuticals in Q1 2024, selling an estimated $80.1M.
  • Armistice Capital's ten largest holdings make up 62% of its $7.54B portfolio in Q1 2024.
  • Armistice Capital opened 139 new positions and closed 95 in Q1 2024.
  • Armistice Capital's portfolio value rose 2.9% quarter-over-quarter to $7.54B.

Based on Armistice Capital's 13F filing for Q1 2024, filed 15 May 2024.